Recombinant Human Serglycin/SRGN Protein，His

Serglycin (SRGN) is a unique proteoglycan primarily found in hematopoietic cells and is characterized by its ability to bind various bioactive molecules, including cytokines, chemokines, and growth factors. Its primary role is believed to involve the regulation of immune responses and cell signaling, particularly in the context of inflammation and tumor progression. Research has shown that Serglycin is involved in the storage and release of these important regulatory molecules, which can influence the behavior of immune cells. There is growing interest in the therapeutic potential of Serglycin, particularly in cancer biology, where it may facilitate tumor growth and metastasis by modulating the tumor microenvironment. Recombinant Serglycin protein production has become a focal point in studies aimed at understanding its structural characteristics, functional roles, and interactions with other molecules. This research not only enhances our comprehension of immune modulation but also opens avenues for developing new strategies in cancer treatment and immunotherapy. By studying the recombinant protein's properties, researchers aim to elucidate the precise mechanisms through which Serglycin exerts its effects, thereby contributing to a more comprehensive understanding of its role in health and disease.